Stroke · 2003 · 77 citations · 9 references
MedicineEmergency MedicineHealth Services AdministrationCerebrovascular NeurosurgeryCerebrovascular SurgeryVascular SurgeryAcute Ischemic StrokeAcute Stroke CareAcute Stroke ManagementCerebrovascular DiseaseHemorrhage ControlStrokeAcute Ischemic Stroke ManagementAcute Ischemic Stroke TreatmentEmergency Stroke InterventionIntravenous Tissue Plasminogen ActivatorPlasminogen ActivatorsRegional Network StrategyStroke Care PathwaysSymptomatic Intracranial Hemorrhage
BACKGROUND AND PURPOSE: We sought to evaluate whether a comprehensive stroke center could work with regional hospitals to increase the use of tissue plasminogen activator (tPA) in acute stroke. METHODS: In 30 months, 142 patients seen at the Mid America Brain and Stroke Institute received tPA. Site of presentation, protocol selection, and outcomes were analyzed. RESULTS: We found that 18.2% (142 of 781) of all ischemic strokes received tPA. Of those, 70% (99 of 142) were transferred from hospitals within 100 miles of Kansas City (Mo). Mortality rate was 12.7% (18 of 142). Symptomatic hemorrhage rate was 9.2%. CONCLUSIONS: A comprehensive stroke center can serve as a hub for a regional network and increase the number of stroke interventions with acceptable outcomes.
9
Early stroke treatment associated with better outcome
John R. Marler, Barbara C. Tilley, Mei Lü et al. · Neurology · 2000 · 872 citations
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
Gregory W. Albers, Vernice Bates, Wayne M. Clark et al. · JAMA · 2000 · 707 citations
Medicine, Neurology, Pharmacotherapy +17
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
Irene Katzan, Anthony J. Furlan, Lynne E. Lloyd et al. · JAMA · 2000 · 659 citations